Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2014-08-30 21:03:39 UTC |
---|
Update Date | 2014-12-24 20:26:52 UTC |
---|
Accession Number | T3D4553 |
---|
Identification |
---|
Common Name | Carbinoxamine |
---|
Class | Small Molecule |
---|
Description | Carbinoxamine is a first generation antihistamine that competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. The product label for carbinoxamine as an over the counter cough and cold medicine is being modified to state "do not use" in children under 4 years of age in order to prevent and reduce misuse, as many unapproved carbinoxamine-containing preparations contained inappropriate labeling, which promoted unapproved uses (including management of congestion, cough, the common cold, and the use in children under 2 years of age), which can potentially cause serious health risks. |
---|
Compound Type | - Amine
- Drug
- Ether
- Food Toxin
- Histamine Antagonist
- Histamine H1 Antagonist
- Organic Compound
- Organochloride
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | (+-)-Carbinoxamine | 2-(P-chloro-alpha-(2-(dimethylamino)Ethoxy)benzyl)pyridine | Allergefon | Arbinoxa | Carbinoxamin | Carbinoxamina | Carbinoxamine base | Carbinoxaminum | Clistin | Histin | Karbinal | Palgic | Paracarbinoxamine | Rotoxamine | Satinmin | {2-[(4-chloro-phenyl)-pyridin-2-yl-methoxy]-ethyl}-dimethyl-amine |
|
---|
Chemical Formula | C16H19ClN2O |
---|
Average Molecular Mass | 290.788 g/mol |
---|
Monoisotopic Mass | 290.119 g/mol |
---|
CAS Registry Number | 486-16-8 |
---|
IUPAC Name | {2-[(4-chlorophenyl)(pyridin-2-yl)methoxy]ethyl}dimethylamine |
---|
Traditional Name | carbinoxamine |
---|
SMILES | CN(C)CCOC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 |
---|
InChI Identifier | InChI=1/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3 |
---|
InChI Key | InChIKey=OJFSXZCBGQGRNV-UHFFFAOYNA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as benzylethers. These are aromatic ethers with the general formula ROCR' (R = alkyl, aryl; R'=benzene). |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzylethers |
---|
Direct Parent | Benzylethers |
---|
Alternative Parents | |
---|
Substituents | - Benzylether
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Pyridine
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Dialkyl ether
- Ether
- Azacycle
- Organoheterocyclic compound
- Organohalogen compound
- Organic nitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organochloride
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | < 25 °C | Boiling Point | 160 °C at 1.00E-01 mm Hg | Solubility | Not Available | LogP | 2.6 |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-0ab9-9000000000-a413c068c7a879eb2068 | 2017-09-12 | View Spectrum | GC-MS | GC-MS Spectrum - EI-B (Non-derivatized) | splash10-0ab9-9000000000-a413c068c7a879eb2068 | 2018-05-18 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0pb9-9180000000-b7d95742727b1ef0a3c4 | 2017-09-01 | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | View Spectrum | LC-MS/MS | LC-MS/MS Spectrum - , positive | splash10-0uxr-0490000000-9ece1371a4992f21aa52 | 2017-09-14 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0006-1090000000-eecfc1a96c21589df023 | 2016-06-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-006x-4090000000-f55a8c538f446792b084 | 2016-06-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-00di-9210000000-cc26b029a0e987b18446 | 2016-06-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-dbe5de39fc21f0c12088 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00kr-0190000000-757e5fdc2e3d83027d7a | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-014i-7890000000-70eeab9a0ba6cc4b2449 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0f6x-0090000000-8e6319ead8805445ce4f | 2021-10-11 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0udi-0090000000-b1b5900f97954c8ed449 | 2021-10-11 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0uk9-5090000000-c844f1f981eb3e25a3bf | 2021-10-11 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-f8ccd79e440175ba372a | 2021-10-11 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0gb9-2190000000-37dda60416c010f365ad | 2021-10-11 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0gb9-4490000000-742d9da4f019f9a49ad2 | 2021-10-11 | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0ab9-9200000000-c3abf61d5cdaa81de77d | 2014-09-20 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Carbinoxamine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. Carbinoxamine's anticholinergic action appears to be due to a central antimuscarinic effect, which also may be responsible for its antiemetic effects, although the exact mechanism is unknown. |
---|
Metabolism |
Half Life: 10 to 20 hours |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | For symptomatic relief of seasonal and perennial allergic rhinitis and vasomotor rhinitis, as well as allergic conjunctivitis caused by foods and inhaled allergens. Also for the relief of allergic reactions to blood or plasma, and the symptomatic management of mild, uncomplicated allergic skin manifestations of urticaria and angioedema. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB00748 |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | 2564 |
---|
ChEMBL ID | CHEMBL864 |
---|
ChemSpider ID | 2466 |
---|
KEGG ID | C06871 |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | 3398 |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Not Available |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Carbinoxamine |
---|
References |
---|
Synthesis Reference | Tilford. C.H. and Shelton, R.S.; U.S. Patent 2,606,195;August 5,1952; assigned to The Wm.S. Merrell Company.
Swain, A.P.; U.S. Patent 2800,485; July 23,1957; assigned to McNeil Laboratories, Inc. |
---|
MSDS | T3D4553.pdf |
---|
General References | - BEALE HD, RAWLING FF, FIGLEY KD: Clistin maleate; a clinical appraisal of a new antihistaminic. J Allergy. 1954 Nov;25(6):521-4. [13211145 ]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|